Yervoy An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resist

[George71]

recent analysis shows that long-term survival after 3, 4 and 5 years is two -- three times higher in the immunotherapy arm as opposed to the placebo arm.

An antibody that targets CTLA-4, a so-called checkpoint inhibitor (CPI), can block this deactivation, thereby reactivating the immune system once again. This reactivated immune response can then help the body to destroy cancer cells,"

sciencedaily.com/releases/2...

[snoraste]

There are a lot of clinical trials with multiple checkpoint inhibitor drugs/combinations. Hopefully they get the cocktail right:

clinicaltrials.gov/ct2/resu...

[j-o-h-n]

Hello George!!!

Good Luck, Good Health and Good Humor.

j-o-h-n Friday 10/09/2020 7:38 PM DST

[George71 in reply to j-o-h-n]

Hi j-o-h-n,

where have you been -- napping?

[j-o-h-n in reply to George71]

Hahaha You know us old guys have to nap once in a while.......

Good Luck, Good Health and Good Humor.

j-o-h-n Friday 10/09/2020 9:21 PM DST